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ABSTRACT
Objectives: The objective of this study was to assess
whether National Institute of Health Research (NIHR)
Health Technology Assessment (HTA)-funded
randomised controlled trials (RCTs) published in the
HTA journal were described in sufficient detail to
replicate in practice.
Setting: RCTs published in the HTA journal.
Participants: 98 RCTs published in the HTA journal
up to March 2011. Completeness of the intervention
description was assessed independently by two
researchers using a checklist, which included
assessments of participants, intensity, schedule,
materials and settings. Disagreements in scoring were
discussed in the team; differences were then explored
and resolved.
Primary and secondary outcome measures:
Proportion of trials rated as having a complete
description of the intervention (primary outcome
measure). The proportion of drug trials versus
psychological and non-drug trials rated as having a
complete description of the intervention (secondary
outcome measures).
Results: Components of the intervention description
were missing in 68/98 (69.4%) reports. Baseline
characteristics and descriptions of settings had the
highest levels of completeness with over 90% of
reports complete. Reports were less complete on
patient information with 58.2% of the journals having
an adequate description. When looking at individual
intervention types, drug intervention descriptions
were more complete than non-drug interventions with
33.3% and 30.6% levels of completeness,
respectively, although this was not significant
statistically. Only 27.3% of RCTs with psychological
interventions were deemed to be complete, although
again these differences were not significant
statistically.
Conclusions: Ensuring the replicability of study
interventions is an essential part of adding value in
research. All those publishing clinical trial data need
to ensure transparency and completeness in the
reporting of interventions to ensure that study
interventions can be replicated.
INTRODUCTION
A recent publication by Chalmers and
Glasziou
1 has suggested that as much as 85%
of the US$100 billion spent on health
research worldwide each year is potentially
wasted due to four key problems of knowl-
edge production and dissemination.
Several studies have speciﬁcally assessed
the waste area for ensuring that the funded
research is unbiased and usable by exploring
the quality and usability of publications from
funded health research. This is a key
concern considering the role effective sum-
maries of evidence have in facilitating knowl-
edge transfer and enhancing the uptake of
ﬁndings in clinical practice. While it is recog-
nised that trial registration databases and sci-
entiﬁc journals can be restrictive in terms of
word allowance, various strategies have been
proposed to improve the reporting of inter-
ventions in the published trials, including an
‘intervention bank’ to include manuals and
ﬁdelity tools linked to trial registration
numbers’.
2
Studies have highlighted concerns about
the descriptions of interventions in ﬁnal
reports and publications. In one study,
for example, 80 consecutive studies were
Strengths and limitations of this study
▪ An externally produced checklist was applied to
all randomised controlled trials published in the
National Institute of Health Research (NIHR)
Health Technology Assessment journal series.
▪ The sample size for a number of assessments is
very small.
▪ The checklist was only applied to the intervention
arm of the trial, in the future it would be import-
ant to apply the checklist fully to both the
control and intervention arm of trials.
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journal Evidence-Based Medicine. Two general practitioners
independently assessed whether they could use the treat-
ment with a patient if they saw them the next day.
3 Of
these 80 published reports, 41 (51%) had elements of
the intervention missing, particularly descriptions of
process and information on handouts or booklets. The
proportion of trials for which adequate information
could be made available increased to 90% through the
checking of references, contacting authors and under-
taking additional searches.
3
Similarly, Schroter et al
4 developed, piloted and
applied a checklist designed to assess the replicability of
published treatment decisions to 51 trials published in
the BMJ. This checklist was applied by the study team to
a broad range of health topics and included seven items
and a global eighth item to summarise completeness.
This study reported that 57% (29/51) of the papers
were not considered to be of sufﬁcient description to
allow replication, with the most poorly described aspects
of the published trials being the sequencing of the tech-
nique and physical/information materials.
4 A further
study
5 has used the checklist developed by Schroter et al
to assess the completeness of non-pharmacological inter-
vention description and reported that only 39% were
adequately described.
Rates of replicability of interventions vary considerably
in the published literature depending on the complexity
of the treatment and the assessment criteria. For
example, three studies assessed compliance with item 4
of CONSORT in published research in the areas of
weight loss,
6 brain tumours
7 and Hodgkin’s lymphoma.
8
Item 4 of CONSORT speciﬁcally asks for precise details
concerning treatments intended for all groups and how
and when they were administered. These studies
reported that over 90% of study ﬁndings were replicable.
In contrast, however, one study assessed whether there
was sufﬁcient information on what happens before,
during and after treatment for back pain, and revealed
that only 13% of the trials were replicable.
9
The National Institute of Health Research (NIHR)
Health Technology Assessment (HTA) Programme com-
missions and funds primary research and evidence syn-
thesis on the effectiveness, costs and broader impact of
healthcare treatments and tests for those who plan,
provide or receive care in the NHS. It aspires to enable
all funded projects to complete and publish in the pro-
gramme’s own journal HTA, freely available on the pro-
gramme’s website (http://www.hta.ac.uk). Reports
published in the journal series are peer reviewed, are in
the public domain and contain a full record of the
study. Unlike typical peer-reviewed journals, there are no
word or size limitations for the full report and unlimited
appendices, thus enabling more detail to be included in
the publication; an average report is approximately
50 000 in length. Given the importance of complete and
replicable reporting of ﬁndings and the opportunities
the NIHR HTA journal present, this study aimed to
assess whether randomised controlled trials (RCTs) with
single trials published in HTA were described in sufﬁ-
cient detail.
METHODS
Data source
All RCTs published in the NIHR HTA journal (from
January 1999 until March 2011) were selected for inclu-
sion in the study. Of the 109 reports published in this
time period, 11 were excluded as they had reported more
than one RCT within a single HTA journal. Ninety-eight
single trial RCTs were therefore included in the study.
Piloting the checklist
Five NIHR HTA-funded RCTs were selected to represent
a range of interventions (surgery, psychology, devices
and pharmaceutical) to pilot the checklist initially devel-
oped by Schroter et al.
4 The checklist was applied inde-
pendently by three assessors to assess the level of
agreement between assessments. A κ score was produced
for each individual trial (range 0.15–0.7) with an
average of 0.225 across all ﬁve trials. Disagreement was
due to differing interpretations of the checklist ques-
tions. The initial checklist was modiﬁed to separate two
of the questions into their individual components. In
the published checklist, the recipient question stated ‘Is
it clear who is receiving the intervention?’ and ‘Do you
know all that you need to about the patients? (eg, which
drugs they are taking, what they were told, etc)?’. We felt
that this required several pieces of information for a
single question and therefore we separated question 2
into the three components, as shown in table 1.
Similarly, the material question, ‘Are the physical or
informational materials used adequately described?’ was
separated into two components, which is shown in ques-
tion 7 of table 1. In addition, the assessors discussed the
type and level of information expected to be present in
order to answer a question as complete. The modiﬁed
checklist was applied by the three assessors to a further
ﬁve NIHR HTA-funded RCTs, resulting in higher levels
of agreement (κ scores for each report ranged from 0.3
to 0.7, with an average of 0.6 for all trials).
The main study
The ﬁnal modiﬁed checklist was applied to a wider
sample of NIHR HTA-funded RCTs. All RCTs published
in the NIHR HTA journal (from January 1999 to March
2011) were selected for inclusion with in the study. One
checklist was completed for the intervention group of
each trial published. Each item in the checklist was
answered by either a yes, no or not applicable response.
We did not apply the full checklist to the Control
Group, but, unlike the published checklist,
4 we did
make a general assessment as to the completeness of
control group information within question 9 of the
checklist. However, responses to this question were not
on a detailed assessment of all components of the
2 Douet L, Milne R, Anstee S, et al. BMJ Open 2014;4:e003713. doi:10.1136/bmjopen-2013-003713
Open Access
  group.bmj.com  on August 20, 2014 - Published by  bmjopen.bmj.com Downloaded from control group, unlike the intervention group itself.
Question 8 summarises whether there are any aspects of
the intervention missing based on the responses to the
previous seven questions.
Data quality
Each trial was assessed independently by two assessors.
Fifteen per cent of the published reports (15/98) were
discussed due to disagreements of the scoring mainly
around checklist item 7. All disagreements were dis-
cussed by the team and were resolved by consensus.
Three assessors carried out the assessments. Each trial
was allocated to two assessors who independently applied
the criteria. None of the assessors had medical or clinical
experience; however, they have higher health degrees
and work full time in health research and in evaluating
clinical research. All NIHR HTA reports were examined
by using a stabilised process, initially scanning the execu-
tive summary, followed by the methods, using key word
search terms to scan the whole document and appendi-
ces and ﬁnally undertaking a detailed reading of the
entire report if relevant information could not be found.
Data analysis
The checklist for each trial was completed using an elec-
tronic, stand-alone access database. The checklists
completed by all three assessors were then merged and
exported into Excel and IBM SPSS V.19 for data analysis.
IBM SPSS software was used to conduct all descriptive and
inferential analyses. The χ
2 test was used for all compari-
sons (statistically signiﬁcant at p<0.05). If any cell had an
expected count less than 5, the Fisher’s exact test was used.
RESULTS
The modiﬁed checklist was applied to 98 RCTs pub-
lished by the HTA journal series from January 1999 until
March 2011. The interventions within each published
trial were classiﬁed by the following intervention types:
pharmaceutical, radiotherapy, surgery, diagnostic, educa-
tion and training, service delivery, psychological, vac-
cines and biological, devices, physical therapy, exercise,
complementary therapy, mixed or complex, and other.
The intervention classiﬁcation was provided by Schroter
et al
4 as part of the original checklist. Table 2 shows the
number of trials within the journal series for each inter-
vention by type.
Applying the modiﬁed checklist to NIHR HTA-funded
RCTs revealed that components of the intervention
description were missing in 68 of the 98 reports (missing
69.4%). Table 3 contains selected examples against six
of the items in the checklist to illustrate complete and
poorly described interventions.
Table 1 Replicability criteria for interventions, developed from an initial design by Schroter et al
3
Checklist criteria Descriptor of criteria where appropriate
1. Setting
Is it clear where the intervention was delivered?
2a. Recipient—inclusion
Is it clear who is receiving the intervention?—inclusion criteria Clear inclusion criteria in the journal
2b. Recipient—exclusion
Is it clear who is receiving the intervention?—exclusion criteria Clear exclusion criteria in journal
2c. Recipient—baseline characteristics
Do you know all that you need to about the patients? (eg, which drugs they
are taking, what they were told, etc)?
If no, what further information do you require?
Baseline characteristics of participants
provided in journal
3. Provider
Is it clear who delivered the intervention?
4. Procedure
Is the procedure (including the sequencing of the technique) of the intervention
sufficiently clear to allow replication?
5. Intensity
Is the dose/duration of individual sessions of the intervention clear?
6. Schedule
Is the schedule (interval, frequency, duration or timing) of the intervention
clear?
Frequency of intervention, length of
session
7a. Materials—physical
Are the physical materials used adequately described?
7b. Materials—informational
Are the informational materials used adequately described?
8. Missing
Is the description of the intervention complete?
If no, what is missing?
9. Control
Is it clear what the control group received during the study?
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30.6% of reports. Certain criteria had high levels of com-
pleteness, such as baseline characteristics (94.9%) and
descriptions of settings (91.8%), which were complete for
over 90% of reports. However, other criteria were notably
less complete, particularly patient information with only
58.2% having an adequate description (table 4).
Differences in completion rates were noted between
the 14 types of interventions. For example, descriptions
of interventions were more complete for drug interven-
tions than for non-drug interventions with 33.3% and
30.6% levels of completeness, respectively. The χ
2 test
showed that this difference was not statistically signiﬁcant
(p=0.77). Furthermore, this was not the case with certain
criteria, such as baseline characteristics (drugs 93.3%,
non-drugs 94.4%) and provider information (drugs 73.3,
non-drugs 77.8%) where levels of completeness were
higher in non-drug trials than in drug interventions.
Descriptions of interventions were found to be least
complete for psychological interventions with only
27.3% of RCTs in this area being complete. The χ
2 test
revealed that this difference was not statistically signiﬁ-
cant when compared with drug interventions (p=1.00).
Again, there were a few occasions where certain criteria
had the highest levels of completeness of all interven-
tion types, in particular with baseline characteristics and
provider information with 100% and 90.9% of complete-
ness, respectively (table 4).
The modiﬁed checklist included a question about the
completeness of the control group. This was not a
detailed evaluation of all the components of the control
group but a broad assessment of whether the descrip-
tion appeared to be complete or not. Given the inter-
pretative nature of this question, control group
information were not included with the full data. The
data revealed that 51% of RCTs had complete descrip-
tions of control groups.
DISCUSSION
Statement of principal findings
This study has revealed that 30.6% (30/98) of studies
with a single trial published in the HTA journal have a
full description of the intervention. The interventions
described in the published RCTs performed well against
certain criteria, such as baseline characteristics (with
95% having an adequate description), but less well on
other criteria, such as patient information (with 58%
having an adequate description). Drug trials were
slightly more complete than non-drug trials and psycho-
logical interventions with 33.3% of journals having a
complete intervention description, although these differ-
ences were not statistically signiﬁcant.
Strengths and weaknesses
The strengths of this study are that externally generated
and tested criteria were applied to evaluate the effective-
ness of intervention descriptions in NIHR HTA
Programme-funded RCTs. However, there were limitations.
First, none of the assessors applying the criteria were med-
ically trained; however, assessors were not commenting on
the suitability of an intervention for use in practice but
were discussing on whether the aspects of the description
would be required for use in practice. There is a possibility
that someone with medical training would score the pro-
jects differently. In a previous work, the authors have been
medically trained. Second, the authors of the reports were
not contacted to provide additional information beyond
that provided in the publication. Previous studies have
demonstrated that contacting the research teams or add-
itional searches for intervention details does increase the
completeness of intervention descriptions.
35However, it is
questionable whether having to undertake additional
searches outside the publication effectively enhances the
ease of replicating study ﬁndings.
A limitation of the checklist used is the type of data
being collected. While all the criteria are dichotomous
(in that they are all yes/no answers), the justiﬁcation
behind this categorisation has different degrees of inter-
pretation. This could have resulted in overly harsh
assessments of completeness for certain criteria. For
example, the recipient criterion is clear (are inclusion/
exclusion criteria present) while greater interpretation is
required for the materials criterion which requires the
assessor to determine whether the description of the
physical materials is adequate and therefore open to
interpretation. Certainly, the completion rate for materi-
als was among the lowest across all studies with 58% and
69% completion rates for informational and physical
materials, respectively. By using this checklist we were
able to suggest further reﬁnements to the criteria used
within it, such as separating out the recipient criteria
and the material criteria.
Table 2 Intervention type of NIHR HTA-funded trial RCTs
included in the study
Type of intervention N (%)
Drug 15 (15.3)
Radiotherapy 1 (1.0)
Surgery 9 (9.2)
Diagnostic 8 (8.2)
Education and training 3 (3.1)
Service delivery 19 (19.4)
Psychological therapies 11 (11.2)
Vaccines and biologicals 3 (3.1)
Devices 12 (12.2)
Physical therapies 7 (7.1)
Exercise 1 (1.0)
Complementary therapies 2 (2.0)
Mixed or complex 6 (6.1)
Other* 1 (1.0)
Total 98
*Other refers to an intervention using larval therapy.
HTA, Health Technology Assessment; RCT, randomised
controlled trial.
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Checklist
item Examples of poor reporting
Reason why rated as
incomplete Examples of good reporting Reason why rated complete
Inclusion
criteria
‘…patient identification was retrospective.
Searches were conducted on practice
databases using either repeat
prescriptions alone or repeat prescriptions
plus diagnostic terms… GPs then sent
letters to suitable patients, providing
information about the trial’
No details given about
the searches and the
criteria patients were
screened with
Inclusion criteria for trial patients were:
▸ Diagnosed with idiopathic arthritides of
childhood with onset before their 16th
birthday for more than 3 months
▸ Aged 4–19 years inclusive
▸ Stable on medication
▸ At least one active joint, core set criteria 1.56
▸ At least two of any five of the remaining core
set criteria below
▸ The physician global assessment of disease
activity >10 mm on a 100-mm VAS
▸ The parent global assessment of well-being
>10 mm on a 100-mm VAS
▸ Childhood Health Assessment Questionnaire
scores >0
▸ More than one joint with limited range of
motion (joint motion reduced by at least 5°
from normative range for age58)
▸ An elevated ESR (>5 mm Hg in children and
>10 mm Hg in adolescents)
Very detailed patient criteria
listed
Exclusion
criteria
‘GPs were given a ringbinder file with
information and instructions about the trial
and, within each, a number of recruitment
packs. The packs contained the
paperwork required to complete the
recruitment of each patient, this was: a
reminder of the inclusion/exclusion criteria
for the study….’
No details given about
the exclusion criteria
Reasons for exclusion (yes/no)
▸ BMI >40 kg/m
2
▸ Barrett’s oesophagus (≥3 cm)
▸ Paraoesophageal hernia
▸ Oesophageal strictures
▸ One type of management is clinically
indicated for another reason
Detailed patient exclusion
criteria listed
Provider ‘All services had staff who were trained
and experienced in family therapy, but not
necessarily family interventions specifically
for eating disorders’
No details about the staff
providing the
interventions or the
training they received
Eight counsellors (six females and two males)
took part in the trial (one worked at two
practices) and all were BACP accredited or
eligible for BACP
accreditation; they were highly trained and had
considerable experience of counselling in a
general practice setting (there are details about
each counsellors age, qualifications and
experience are provided)
States who delivered the
intervention and their training
Procedure ‘Generally home-based rehabilitation
services provide, as a minimum,
physiotherapy and occupational therapy in
No details about the
services provided to
The content of the CBT programme included
(complete course description contained within
an appendix):
Key aspects of the intervention
summarised in the text and a
full description of the
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 Table 3 Continued
Checklist
item Examples of poor reporting
Reason why rated as
incomplete Examples of good reporting Reason why rated complete
the patient’s own home. Services can be
specialised (eg, in stroke rehabilitation) or
be provided for patients with a range of
disabilities’
patients and variation
between centres
▸ Elucidation of core beliefs regarding their
illness and its management
▸ Monitoring of activity levels and introduction
of appropriate timetable
▸ Introduction to exercises designed to
increase general level of fitness, balance and
confidence in exercise. A range of aerobic,
strength, balance and stretching exercises
were taught
▸ Behavioural modification of sleep patterns
▸ Mood management advice
▸ Goal setting
intervention is detailed in the
appendices
Intensity
and
schedule
‘Patients come to the day hospital where
the rehabilitation service is provided for a
full or half day. Usually ambulance
transport is provided to bring patients into
the service and return them home after a
session’
No details of the length
or number of sessions
Psychological treatment was based on existing
protocols (references included) and distributed
over six 50-minute sessions, with printed
information sheets provided after each session
The length and number of
sessions is included as well as
the details of each session
Materials—
physical
‘The acupuncture point prescriptions used
were individualised to each patient and
were at the discretion of the acupuncturist’
The prescriptions used
are not detailed
▸ 500 mg oral oxytetracycline (non-proprietary)
twice daily+topical vehicle control twice daily
▸ 100 mg oral Minocin MR minocycline) once
daily+topical vehicle control twice daily
▸ Topical Panoxyl Aquagel (5% benzoyl
peroxide) twice daily+oral placebo once daily.
This was designated as the active comparator
group, as benzoyl peroxide was the leading
and most established topical treatment for
acne when the protocol was written
▸ Topical Benzamycin (3% erythromycin+5%
benzoyl peroxide) twice daily+oral placebo
once daily (referred to as ery.+BP twice daily)
▸ Topical Stiemycin (2% erythromycin) once
daily+topical Panoxyl Aquagel (5% benzoyl
peroxide) once daily+oral placebo once daily
(referred to as ery. once daily+ BP once
daily)
Each of the treatments
prescribed is clearly defined
BACP, British Association for Counselling & Psychotherapy; BP, blood pressure; CBT, cognitive behavioural therapy; ESR, erythrocyte sedimentation rate; GP, general practitioner; HTA, Health
Technology Assessment; VAS, visual analogue scale.
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 A further limitation of the study was that the checklist
was not fully applied to the control group of the published
trials. This would have provided a more complete picture
of how well controls are described within a study. Another
limitation was that the number of journals assessed for
completeness was very small for certain assessments (eg,
only 11/98 journals reported psychological interven-
tions). Therefore, it is possible that certain ﬁndings of
completeness rate occurred by chance.
Meanings of the study
It is tempting to make comparisons with others studies
assessing the usability of intervention descriptions. In par-
ticular, Glasziou et al
3 reported that 41/80 (51%) of the
published reports of single randomised trials and system-
atic reviews in popular journals were complete compared
with 30/98 (30.6%) completeness of NIHR HTA-funded
RCT trials. Similarly, interventions in NIHR HTA reports
appeared to be described less well than the 51 trials pub-
lished in the BMJ assessed by Schroter et al
4 where 43%
(22/51) of the articles were considered to be of with sufﬁ-
cient description to allow replication. While these com-
parisons are interesting, it is important to note that it is
not possible to make any meaningful comparison on the
relative performance of each output, as the Glasziou et al
3
study looked at journal articles and we looked at the HTA
journal series which are aimed at different audiences and
the questionnaire used was different between the studies.
This is because the nature of outputs varies considerably
between studies as does the assessment criteria. It is
notable, for example, that Schroter et al
4 used eight indica-
tors (7 main checklist items and a global completeness
eighth item) in their checklist, compared with the 12 cri-
teria used in this study.
However, this study does reﬂect ﬁndings from similar
studies conducted elsewhere. For example, the criteria
highlighted as being particularly poorly described in
Schroter’s study were physical/informational materials,
which reﬂected ﬁndings in this study where patient infor-
mation and physical materials were also lacking in com-
pleteness. Similarly, the fact that NIHR HTA
Programme-funded drug interventions were typically
better described than non-drug interventions reﬂected
the ﬁndings in Glasziou et al
3 where over 60% of reports
on drug treatments were initially deemed to be complete
compared with just under 30% of non-drug treatments.
In addition to the more detailed guidance provided to
authors, the HTA journal requests that authors of RCTs
include the headings set out in the revised CONSORT
checklist and ﬂowchart and provide details of
CONSORT in its guidance for authors. Item 5 of the
CONSORT statement says ‘The interventions for each
group with sufﬁcient details to allow replication, includ-
ing how and when they were actually administered’ and
there are extensions of the CONSORT statement to
address the additional complexity around the reporting
of non-pharmacological interventions. The CONSORT
extensions are not currently a requirement for non-
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more widely requested, it is hopeful that the reporting
of interventions will improve and be fully described.
A number of studies have investigated the complete-
ness of intervention descriptions in a single disease area
by assessing the compliance of RCTs with the interven-
tion item (item 4) of the CONSORT statement.
6–8 While
these studies reported that over 90% of study ﬁndings
were replicable, it is likely that this is an over estimation
as they do not assess the question of whether there was
enough information to allow replication. In contrast,
however, one study assessed whether there was sufﬁcient
information on what happens before, during and after
treatment for back pain, and revealed that only 13% of
the trials were replicable.
8
Understanding the extent to which interventions in
the published studies are described sufﬁciently to
inform clinical decision-making is a key concern in
adding value in research agenda. As Chalmers and
Glasziou
1 have suggested, poorly described interventions
form one of the four main pillars of research waste. The
criteria identiﬁed by Schroter et al
4 and developed in
this study are helpful in highlighting the speciﬁc areas
of where intervention descriptions can be improved.
Future research
Several areas for further research are indicated by this
study. Further testing on the criteria can be undertaken
to assess the repeatability of the criteria. For example,
the reports sampled in this study could be reassessed by
someone with clinical experience to assess the level of
agreement. Alternatively, Glasziou’s selected papers in
his original study could be assessed by non-clinical teams
to examine the level of agreement. The checklist has
only been applied to single trial studies; future research
into the applicability of it for multitrial studies should be
investigated.
The characterisation of the control group is a key area
for future research, as research involving trials to date
has focused on the description of interventions with a
treatment group; however, the detail of the control arm
is equally important as in many cases the control arm is
often described as ‘usual care’ but this does not take
into account variations by centre.
10 A recent paper
reported on the development of a tool for extraction of
data in systematic reviews and includes an element on
intervention design.
11 The tool has been applied to the
intervention and control groups of systematic reviews.
The applicability of the tool across primary research
could be investigated and used to further strengthen the
checklist that we have used.
Ensuring the replicability of study ﬁndings is an essen-
tial part of adding value in research. It is important for
health research publishers to be transparent in the
usability of study reports and areas of improvement. This
study applied a checklist that can be used to indicate
where the descriptions of interventions can be improved
to enhance replication in clinical practice. Serious
consideration should be given on how this might be
used to improve intervention reporting in the future.
The results of this study have been shared with the edi-
torial Board of the HTA journal to investigate how inter-
ventions can be better reported within a journal series.
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